世界のインシュリン市場動向2018...市場調査レポートについてご紹介

1. Analyst View
2. Research Methodology
3. Global Protein Therapeutics Market
3.1 Protein Therapeutics Market vs Pharmaceutical Market
3.2 Current and Future Market Analysis to 2018
3.2.1 Market Segmentation
4. Insulin Market Forecast to 2018
4.1 Scientific Insight
4.2 Current and Future Market Analysis to 2018
4.3 Key Players and Drugs
4.4 By Type of Insulin
4.4.1 Mode of Action
4.4.2 Mode of Synthesis
4.5 By Application
4.5.1 Regional Analysis
4.6 Key Geographical Markets
4.6.1 India
4.6.2 China
4.6.3 US
4.6.4 Russia
4.6.5 Japan
4.6.6 Brazil
5. Patent Expiry Status of Insulin
6. Key Players
6.1 Sanofi-Aventis
6.2 Novo Nordisk
6.3 Eli Lilly & Company
6.4 Wockhardt
6.5 Biocon

List of Figures:

Figure 3-1: Global – Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2013
Figure 3-2: Global – Protein Therapeutics Market (Billion US$), 2013-2018
Figure 3-3: Global – Protein Therapeutics Market by Segment (%), 2013
Figure 3-4: Global – Forecast for Protein Therapeutics Market by Segment (%), 2018
Figure 4-1: Global – Insulin Market (Billion US$), 2013-2018
Figure 4-2: Global – Share of Key Players in Insulin Market (2013)
Figure 4-3: Global – Share of Products in Insulin Market (2013)
Figure 4-4: Insulin Market by Mode of Action (%), 2013
Figure 4-5: Insulin Market by Mode of Action (%), 2018
Figure 4-6: Insulin Market by Mode of Synthesis (%), 2013
Figure 4-7: Insulin Market by Mode of Synthesis (%), 2018
Figure 4-8: Global – Number of Diabetic Patients (Million), 2013 & 2035
Figure 4-9: Diabetes Prevalence by Region (%), 2013
Figure 4-10: Diabetes Prevalence by Region (%), 2035
Figure 4-11: India – Insulin Market (Million US$), 2013-2018
Figure 4-12: China – Insulin Market (Billion US$), 2013-2018
Figure 4-13: US – Insulin Market (Billion US$), 2013-2018
Figure 4-14: Russia – Insulin Market (Million US$), 2013-2018
Figure 4-15: Japan – Insulin Market (Billion US$), 2013-2018
Figure 4-16: Brazil – Insulin Market (Million US$), 2013-2018

List of Tables:

Table 4-1: Key Insulin Product Sales (Billion US$), 2010-2013
Table 4-2: India – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
Table 4-3: China – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
Table 4-4: US – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
Table 4-5: Russia – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
Table 4-6: Japan – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
Table 4-7: Brazil – Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
Table 5-1: Global – Patent Expiry Status of Key Insulin Products
Table 6-1: Sanofi-Aventis – Insulin Products
Table 6-2: Novo Nordisk – Insulin Products
Table 6-3: Eli Lilly – Insulin Products
Table 6-4: Wockhardt – Insulin Products
Table 6-5: Biocon – Insulin Products